Shilpa Medicare Ltd. (SHILPAMED): Shilpa Medicare Share Price hits fresh 52-week high as stock rises to Rs 863

Published: 27 August 2026 at 9:29 AM IST

Shilpa Medicare Share Price moved to Rs 863 on 27 August 2026, up 0.34% from the previous close of Rs 860.1, after the stock touched a fresh 52-week high of Rs 875.95. The company’s market capitalisation stood at Rs 16,862.09 crore, placing the move in a clearly measurable valuation context for Shilpa Medicare Ltd. (SHILPAMED). The day’s low was Rs 859.55 and the open was Rs 868.95, while turnover stood at Rs 0.97 crore. This Shilpa Medicare Share Price news confirms the price event, but the supplied data does not establish a company-specific catalyst. For readers tracking Shilpa Medicare Share Price Today, the key point is that the stock has registered a yearly high and is trading close to that level in the latest session. Univest is following the stock as part of its fresh 52-week-high coverage.

Shilpa Medicare Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 863
Previous Close	Rs 860.1
Today's Move	+Rs 2.9 (+0.34%)
Open	Rs 868.95
High	Rs 875.95
Low	Rs 859.55
Turnover	Rs 0.97 crore
Market Capitalisation	Rs 16,862.09 crore

Shilpa Medicare Ltd. (SHILPAMED) traded at Rs 863 versus the previous close of Rs 860.1, a rise of 0.34%. The stock opened at Rs 868.95, reached a high of Rs 875.95 and touched a low of Rs 859.55.

Shilpa Medicare Share Price today reflected a narrow net gain of Rs 2.9 from the previous close, with the session range spanning Rs 859.55 to Rs 875.95. The stock opened at Rs 868.95 and matched its 52-week high at Rs 875.95 during the session, which makes the latest Shilpa Medicare Share Price update important for market tracking. The current price of Rs 863 is only modestly above the previous close of Rs 860.1, so the end-of-session move was limited even though the intraday range reached a fresh yearly high. Turnover of Rs 0.97 crore provides the only verified traded-value reference for the day. In Shilpa Medicare Stock News terms, the market event is simple: the stock registered a new 52-week high and then settled below it, leaving the price close to the upper end of the day’s band. Univest presents this as a factual price event rather than a stated cause.

Shilpa Medicare Ltd. (SHILPAMED) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 16,862.09 crore
P/E Ratio	56.58x
P/B Ratio	6.26x
ROE	9.82%
ROCE	11.43%
EPS	Rs 15.2
Book Value Per Share	Rs 137.34
Dividend Yield	0.07%

Shilpa Medicare Ltd. (SHILPAMED) fundamental metrics show P/E 56.58x, P/B 6.26x, ROE 9.82%, ROCE 11.43%. These figures provide context only and are not a buy or sell signal.

Shilpa Medicare Ltd. has a market capitalisation of Rs 16862.09 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 56.58x, P/B at 6.26x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.82% and ROCE of 11.43%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 15.2, book value per share of Rs 137.34, dividend yield of 0.07%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.54x, median ROE of 11.91%, median ROCE of 14.02%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	56.58x
Benchmark Median P/E	30.54x
Benchmark Average P/E	47.11x
Benchmark P/E Range	3.19x to 671.51x
Company P/B Ratio	6.26x
Benchmark Median P/B	2.76x
Company ROE	9.82%
Benchmark Median ROE	11.91%
Company ROCE	11.43%
Benchmark Median ROCE	14.02%
Company Market Capitalisation	Rs 16,862.09 crore
Benchmark Median Market Cap	Rs 623.8 crore

Shilpa Medicare Ltd. (SHILPAMED) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 56.58x, which is above the benchmark median of 30.54x, a difference of +85.27%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Shilpa Medicare Ltd. (SHILPAMED) has a ROE of 9.82%, which is below the benchmark median of 11.91%, a difference of -17.55%. Shilpa Medicare Ltd. (SHILPAMED) has a ROCE of 11.43%, which is below the benchmark median of 14.02%, a difference of -18.47%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Glenmark Life Sciences Ltd.	ALIVUS	16,722.7	27.73	4.8	18.41	24.61
Suven Pharmaceuticals Ltd.	COHANCE	17,040.89	166.41	4.57	14.2	18.44
Concord Biotech Ltd.	CONCORDBIO	16,205.05	58.61	7.78	13.54	18.04
Astrazeneca Pharma India Ltd.	ASTRAZEN	17,888.63	105.46	19.78	23.02	31.24
Alembic Pharmaceuticals Ltd.	APLLTD	15,794.83	23.35	2.77	12.35	11.74

Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 56.58x compared with the displayed peer median of 58.61x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.82% compares with a peer median of 14.2% across the companies shown in the table. ROCE stood at 11.43% versus the displayed peer median of 18.44%, providing a capital-efficiency comparison. Shilpa Medicare Ltd. (SHILPAMED) has a market capitalisation of Rs 16,862.09 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Shilpa Medicare

• Shilpa Medicare Share Price touched a fresh 52-week high of Rs 875.95 in the latest session.
• The stock closed at Rs 863, compared with the previous close of Rs 860.1.
• Market capitalisation stood at Rs 16,862.09 crore.
• P/E is 56.58 and P/B is 6.26, both above the industry median in the supplied benchmark.
• Revenue and net profit both rose in the supplied quarterly figures, with Jun 2026 revenue at Rs 4,657.8 crore and net profit at Rs 1,008.8 crore.

About Shilpa Medicare

Shilpa Medicare Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company profile supplied for this Shilpa Medicare Share Price update supports a focused discussion on market capitalisation, valuation, earnings and peer positioning. For readers tracking Shilpa Medicare Stock News, the relevant verified details today are the listed sector, industry classification, market capitalisation, earnings metrics and the fresh 52-week high event. Univest keeps the company note factual and limited to the supplied data.

Track Shilpa Medicare Share Price on Univest

Use Shilpa Medicare Ltd. (SHILPAMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Frequently Asked Questions

What is Shilpa Medicare Share Price today?

Ans. Shilpa Medicare Share Price today is Rs 863, up 0.34% from the previous close of Rs 860.1. The stock also touched a fresh 52-week high of Rs 875.95 during the session.

Did Shilpa Medicare reach a new 52-week high?

Ans. Yes. Shilpa Medicare Share Price touched Rs 875.95, which is its fresh 52-week high in the latest session. The stock later traded at Rs 863, remaining close to that intraday peak.

What is Shilpa Medicare’s market capitalisation?

Ans. Shilpa Medicare’s market capitalisation stood at Rs 16,862.09 crore in the supplied data. This places the company far above the benchmark industry median market cap of Rs 623.8 crore. The company operates in the Healthcare sector.

What do the valuation ratios show for Shilpa Medicare Share Price?

Ans. The company’s P/E is 56.58 and P/B is 6.26. Both are above the industry median and average in the supplied sector snapshot, so the valuation sits above the central benchmark.

How profitable is Shilpa Medicare?

Ans. Shilpa Medicare reports ROE of 9.82 and ROCE of 11.43. Both are below the benchmark medians in the supplied sector snapshot, which gives the price move an important earnings context.

What are Shilpa Medicare’s EPS and book value?

Ans. EPS is Rs 15.2 and book value per share is Rs 137.34. These two figures help frame the current Shilpa Medicare Share Price alongside earnings and accounting value per share.

Does Shilpa Medicare pay a dividend?

Ans. The supplied dividend yield is 0.07, which indicates a very small historical payout relative to the current share price. Investors can use this with EPS and book value for context.

Which sector and industry does Shilpa Medicare belong to?

Ans. Shilpa Medicare belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That classification is important for comparing Shilpa Medicare Share Price with its sector benchmark and peers. The stock belongs to the Healthcare sector.

How does Shilpa Medicare compare with peers on valuation?

Ans. Shilpa Medicare’s P/E of 56.58 is above Glenmark Life Sciences and Alembic Pharmaceuticals, below Suven Pharmaceuticals and Astrazeneca Pharma India, and close to Concord Biotech in the supplied peer set.

Where can I track Shilpa Medicare Share Price news?

Ans. You can track Shilpa Medicare Share Price on Univest for live price updates, market capitalisation, financial ratios, shareholding pattern and 52-week levels. The platform also groups stock news and company details in one view.